Single-Cell Transcriptomic Analysis of SARS-CoV-2 Reactive CD4 + T Cells
Benjamin J Meckiff1,2, Ciro Ramírez-Suástegui1,2, Vicente Fajardo1,2
1La Jolla Institute for Immunology, La Jolla, CA, USA.
SSRN
|August 4, 2020
Summary
Severe COVID-19 is linked to more cytotoxic CD4+ T cells and fewer regulatory T cells. These cytotoxic CD4+ T cells may recruit other immune cells to infection sites, influencing disease severity.
Area of Science:
- Immunology
- Virology
- Genomics
Background:
- The role of CD4+ T cells in SARS-CoV-2 immunity is unclear.
- Understanding CD4+ T cell responses is crucial for developing effective COVID-19 treatments.
Approach:
- Single-cell transcriptomic analysis of viral antigen-reactive CD4+ T cells from 32 COVID-19 patients.
- Comparison of T cell populations between mild and severe disease cases.
Key Points:
- Severe COVID-19 patients showed increased cytotoxic T helper cells (CD4-CTLs) and follicular helper T cells (TFH), and decreased regulatory T cells.
- CD4-CTLs express chemokines that recruit myeloid and dendritic cells to infection sites.
- T helper 1 (TH1) and T helper 17 (TH17) cells were less common in SARS-CoV-2 responses compared to influenza.
Conclusions:
- Distinct CD4+ T cell profiles correlate with COVID-19 severity.
- These findings offer insights into the T cell-mediated immune response to SARS-CoV-2.
More Related Videos
06:03Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
1.6K
09:08Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021
6.1K
